Cornerstone Therapeutics to Present at Two Upcoming Investor Conferences

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Crism Therapeutics Corporation	LSE:CRTX	London	Ordinary Share	VGG042401262	ORD NPV

Share Name

Share Symbol

Market

Type

Share ISIN

Share Description

Crism Therapeutics Corporation

LSE:CRTX

London

Ordinary Share

VGG042401262

ORD NPV

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	0.00	0.00%	11.50	11.00	12.00	24.00		24.00	145,573	16:26:49

Price Change

% Change

Share Price

Bid Price

Offer Price

High Price

Low Price

Open Price

Shares Traded

Last Trade

0.00

0.00%

11.50

11.00

12.00

24.00

145,573

16:26:49

Industry Sector	Turnover	Profit	EPS - Basic	PE Ratio	Market Cap
	0	0		N/A	0

Industry Sector

Turnover

Profit

EPS - Basic

PE Ratio

Market Cap

N/A

Cornerstone Therapeutics to Present at Two Upcoming Investor Conferences

03/09/2009 1:00pm

PR Newswire (US)

Crism Therapeutics (LSE:CRTX)
Historical Stock Chart

From Jun 2019 to Jun 2024

Click Here for more Crism Therapeutics Charts.

CARY, N.C., Sept. 3 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (NASDAQ:CRTX), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory market, today announced that Craig A. Collard, President and Chief Executive Officer, will be presenting a corporate overview at two upcoming investor conferences. Mr. Collard will first present at the Thomas Weisel Partners Healthcare Conference 2009 at 4:25 PM ET on Wednesday, September 9th, 2009, at the Four Seasons Hotel in Boston, MA. He will then deliver the Company's corporate overview at the Rodman & Renshaw 11th Annual Healthcare Conference at 9:10 AM ET on Thursday, September 10th, 2009, at the New York Palace Hotel in New York City. Both conferences will be held from September 9th - 11th, 2009. Live audio and archived webcasts of Cornerstone's presentations will be available through the Investor Relations section of the Company's website. About Cornerstone Therapeutics Cornerstone Therapeutics Inc. (NASDAQ:CRTX), headquartered in Cary, N.C., is a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory market. The Company currently promotes multiple marketed products in the United States to respiratory-focused physicians and key retail pharmacies with its specialty sales force. The Company also has a late-stage clinical pipeline with five regulatory approval submissions targeted within the next three years. Key elements of the Company's strategy are to in-license or acquire rights to underpromoted, patent-protected, branded respiratory pharmaceutical products, or late-stage product candidates; implement life cycle management strategies to maximize the potential value and competitive position of the Company's currently marketed products, newly acquired products and product candidates that are currently in development; grow product revenue through the Company's specialty sales force which is focused on the respiratory market; and maintain and strengthen the intellectual property position of the Company's currently marketed products, newly acquired products and product candidates. Investor Relations Contacts: FD Evan Smith/Brian Ritchie 212-850-5600 / Media Relations Contact: FD Robert Stanislaro 212-850-5600 DATASOURCE: Cornerstone Therapeutics Inc. CONTACT: Investor Relations, Evan Smith, , or Brian Ritchie, , or Media Relations, Robert Stanislaro, , all of FD, +1-212-850-5600

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

CRTX Crism Therapeutics Corporation